#United States #London #Alimentiv #IBUS #IUS-STAR

Enhancing Clinical Trials Training

In a significant move to improve clinical research standards, Alimentiv Inc. has announced the expansion of its partnership with the International Bowel Ultrasound Group (IBUS). This collaboration aims to enhance the proficiency of professionals in medical imaging through the introduction of the IUS Standardized Training and Acquisition for Research (IUS-STAR) certificate program. This innovative program provides advanced training for sonographers, radiologists, and technologists, equipping them with the necessary skills for clinical studies using intestinal ultrasound (IUS).

What is IUS-STAR?

The IUS-STAR initiative focuses on creating a scalable, structured training and certification program specifically designed for professionals involved in clinical trials. By combining optimized e-learning with practical imaging techniques and detailed iterative assessments, this program aims to enable clinicians to generate high-quality imaging data that adhere to clinical study protocols. The focus on feedback and iterative learning aims to instill confidence and competence in healthcare professionals, thus bridging the gap between academia and practical, clinical execution.

Stephanie Gonzalez, Chief Operations Officer of Alimentiv, articulated the benefits of this collaboration, highlighting how the synergy between IBUS's scientific expertise and Alimentiv's operational capabilities will expedite the establishment of research sites. This results in a growing pool of qualified centers ready to conduct IUS-related studies in inflammatory bowel diseases (IBD).

Why is This Important?

Since launching their exclusive partnership in 2022, Alimentiv and IBUS have led the standardization and implementation of IUS in over 34 countries, marking a significant advancement in non-invasive imaging modalities for IBD research. This partnership emphasizes the pressing need for precision in patient monitoring and treatment in clinical environments. As Kerri Novak, President of IBUS, stated, the importance of IUS lies not only in its ability to enhance the detection and assessment of active disease but in making participation in clinical trials more accessible to patients worldwide.

Additionally, the program aims to improve understanding of disease processes and therapeutic responses, which ultimately benefits patient care. The structured training pathway provided by IUS-STAR allows participants to engage with expert discussions, receive constructive feedback, and demonstrate their proficiency through certification.

Commitment to Quality Data

The primary objective of this collaboration is to ensure the highest possible quality and consistency of ultrasound images captured during clinical trials. Together, Alimentiv and IBUS are dedicated to advancing education, standardization, and innovation in intestinal ultrasound, thereby supporting researchers, study centers, sponsors, and ultimately, patients dealing with gastrointestinal diseases.

For those interested in learning more about the IUS-STAR program, inquiries can be directed to [email protected]

About Alimentiv

Alimentiv is a global contract research organization (CRO) specializing in gastrointestinal pathways. With over 30 years of experience in clinical study science and gastrointestinal medical research and development, Alimentiv partners with pharmaceutical and biotechnology firms. Their commitment to improving treatment outcomes for patients with gastrointestinal conditions is reflected in their comprehensive range of services.

Headquartered in London, Ontario, Canada, Alimentiv operates globally with offices throughout Canada, the United States, Europe, the Asia-Pacific region, and Latin America. To learn more, visit alimentiv.com.

About IBUS

The International Bowel Ultrasound Group is a non-profit organization composed of experts dedicated to expanding the application of intestinal ultrasound. They play a pivotal role in training gastroenterologists and other specialists interested in reinforcing their practice with IUS. The group also fosters research collaborations focused on chronic inflammatory bowel diseases, ultimately aiming to improve personalized patient care through education, research, and clinical application of IUS methodologies. Additional information is available at www.ibus-group.org.